Experience of Long-Term (9 Years) Administration of Tocilizumab in Female Patient with Systemic Onset Juvenile Arthritis: Case Study
Background. Systemic onset juvenile arthritis is a chronic disease of childhood. Its severity is determined by systemic manifestations, high risk of complications, such as macrophage activation syndrome, interstitial lung disease, and persistent polyarthritis with severe functional disorders. Geneti...
Saved in:
| Main Authors: | Maria I. Kaleda (Author), Irina P. Nikishina (Author), Tamara N. Pachkoria (Author) |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2022-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TOCILIZUMAB IN THE TREATMENT OF CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS: ANALYSIS OF FACTORS INFLUENCING THE THERAPY EFFICIENCY IN THE LONG TERM
by: M. I. Kaleda, et al.
Published: (2015) -
Experience of the Tocilizumab Application in Systemic Onset Juvenile Arthritis
by: A. V. Krasnopol'skaja, et al.
Published: (2015) -
Pulmonary Involvement in Systemic Onset Juvenile Arthritis: Current Status of the Problem
by: Maria I. Kaleda, et al.
Published: (2021) -
The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
by: Srdjan Pasic, et al.
Published: (2011) -
Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
by: Hofer M, et al.
Published: (2011)